| Name | Title | Contact Details |
|---|
AnHeart is a clinical stage global biopharmaceutical company developing novel precision oncology therapeutics. Its lead candidate, taletrectinib, is a next-generation ROS1 and NTRK inhibitor currently in Phase 2 trials in first and second-line non-small cell lung cancer (NSCLC). AnHeart is developing a broad pipeline of next-generation precision oncology therapeutics in areas of high unmet medical need.
Access Bio Inc is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vital Pharma Inc. is a West Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Liquidia Technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles.